Initial antimicrobial management of sepsis

MS Niederman, RM Baron, L Bouadma, T Calandra… - Critical care, 2021 - Springer
Sepsis is a common consequence of infection, associated with a mortality rate> 25%.
Although community-acquired sepsis is more common, hospital-acquired infection is more …

Burden of community-acquired pneumonia and unmet clinical needs

J Ferreira-Coimbra, C Sarda, J Rello - Advances in therapy, 2020 - Springer
Community-acquired pneumonia (CAP) is the leading cause of death among infectious
diseases and an important health problem, having considerable implications for healthcare …

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

L Evans, A Rhodes, W Alhazzani, M Antonelli… - Critical care …, 2021 - journals.lww.com
Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to
infection (1). Sepsis and septic shock are major healthcare problems, impacting millions of …

Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases …

JP Metlay, GW Waterer, AC Long… - American journal of …, 2019 - atsjournals.org
Background: This document provides evidence-based clinical practice guidelines on the
management of adult patients with community-acquired pneumonia. Methods: A …

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

I Martin-Loeches, A Torres, B Nagavci, S Aliberti… - Intensive care …, 2023 - Springer
Purpose Severe community-acquired pneumonia (sCAP) is associated with high morbidity
and mortality, and whilst European and non-European guidelines are available for …

Updates on community acquired pneumonia management in the ICU

GB Nair, MS Niederman - Pharmacology & therapeutics, 2021 - Elsevier
While the world is grappling with the consequences of a global pandemic related to SARS-
CoV-2 causing severe pneumonia, available evidence points to bacterial infection with …

Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients

MI Restrepo, BL Babu, LF Reyes… - European …, 2018 - Eur Respiratory Soc
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to
the antibiotics used most frequently in patients with community-acquired pneumonia (CAP) …

Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies

JA Ramirez, DM Musher, SE Evans, CD Cruz… - Chest, 2020 - Elsevier
Background Community-acquired pneumonia (CAP) guidelines have improved the
treatment and outcomes of patients with CAP, primarily by standardization of initial empirical …

Prevalence and etiology of community-acquired pneumonia in immunocompromised patients

MF Di Pasquale, G Sotgiu, A Gramegna… - Clinical Infectious …, 2019 - academic.oup.com
Background The correct management of immunocompromised patients with pneumonia is
debated. We evaluated the prevalence, risk factors, and characteristics of …

Challenges in severe community-acquired pneumonia: a point-of-view review

A Torres, JD Chalmers, CS Dela Cruz… - Intensive care …, 2019 - Springer
Purpose Severe community-acquired pneumonia (SCAP) is still associated with substantial
morbidity and mortality. In this point-of-view review paper, a group of experts discuss the …